Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies
2010
Regulation of tyrosine hydroxylase promoter activity by the von Hippel–Lindau tumor suppressor protein and hypoxia‐inducible transcription factors
2003
Protein-nanoparticle interactions
2008
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
2016 StandoutNature
TMEM127Screening in a Large Cohort of Patients with Pheochromocytoma and/or Paraganglioma
2012
Incorporation of obidoxime into human serum albumin nanoparticles: optimisation of preparation parameters for the development of a stable formulation
2010
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity
2006 Standout
Triglycerides and Cardiovascular Disease
2011
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial
2013
The metabolic syndrome
2010 Standout
Randomized Controlled Trial on the Efficacy and Safety of Atorvastatin in Patients with Type 2 Diabetes on Hemodialysis (4D Study): Demographic and Baseline Characteristics
2004
Extracellular phospholipases in atherosclerosis
2010
Oxidized low density lipoprotein and innate immune receptors
2003
Τhe role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma
2009
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy
2009
Nanoparticulate Transport of Oximes over an In Vitro Blood-Brain Barrier Model
2010
Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration
2003
Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery
2012
Ca2+/Calmodulin Kinase-dependent Activation of Hypoxia Inducible Factor 1 Transcriptional Activity in Cells Subjected to Intermittent Hypoxia
2004 StandoutNobel
Severe Sepsis and Septic Shock
2013 Standout
Physiological aspects of high-altitude pulmonary edema
2005
Lessons from phase III clinical trials on anti-VEGF therapy for cancer
2006
New Structural Scaffolds for Centrally Acting Oxime Reactivators of Phosphylated Cholinesterases
2011 StandoutNobel
Acute Pancreatitis
2016 Standout
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
2007 StandoutNature
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
2015 Standout
Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas
2011
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Tau phosphorylation: physiological and pathological consequences
2004
The metabolic syndrome
2005 Standout
The Epidemiology of Pancreatitis and Pancreatic Cancer
2013 Standout
Angiogenesis in life, disease and medicine
2005 StandoutNature
Treating metastatic cancer with nanotechnology
2011
In vivo genome editing using Staphylococcus aureus Cas9
2015 StandoutNature
Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor Penetration
2011 StandoutNobel
Malignant Gliomas in Adults
2008 Standout
VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer
2009
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Lipoprotein-Associated Phospholipase A2: An Independent Predictor of Coronary Artery Disease Events in Primary and Secondary Prevention
2008
Genetic predisposition to respiratory infection and sepsis
2011
The Role of Apolipoprotein E in Alzheimer's Disease
2009
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
VHL, the story of a tumour suppressor gene
2014
Origin and physiological roles of inflammation
2008 StandoutNature
The Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity and Cardiovascular Biomarkers in Patients With Stable Coronary Heart Disease or Coronary Heart Disease Risk Equivalent
2008
Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines
2003
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
Low-Density Lipoprotein Size and Cardiovascular Disease: A Reappraisal
2003
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
2006 Standout
Increasing the Levels of Insulin-Like Growth Factor-I by an IGF Binding Protein Inhibitor Produces Anxiolytic and Antidepressant-Like Effects
2007
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
2012
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Tumor Angiogenesis
2008 Standout
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Genetic polymorphisms in sepsis
2005
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia
2005
HIF-1α is required for development of the sympathetic nervous system
2019 StandoutNobel
Expression of CD68 and Macrophage Chemoattractant Protein-1 Genes in Human Adipose and Muscle Tissues
2005
Heme Oxygenases in Cardiovascular Health and Disease
2016
Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysis
2012
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Surface-Enhanced Raman Spectroscopy for Bioanalysis: Reliability and Challenges
2018 Standout
Functional Consequences of Mutations and Polymorphisms in the Coding Region of the PAF Acetylhydrolase (PAF-AH) Gene
2009
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Increased PAFAH and Oxidized Lipids Are Associated With Inflammation and Atherosclerosis in Hypercholesterolemic Pigs
2009
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions
2013
Lipoprotein-Associated and Secreted Phospholipases A 2 in Cardiovascular Disease
2010
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
2003
Cytokine Storm
2020 Standout
Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis
2005
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
pVHL suppresses kinase activity of Akt in a proline-hydroxylation–dependent manner
2016 StandoutScienceNobel
Drug delivery and nanoparticles: Applications and hazards
2008 Standout
The Val279Phe Variant of the Lipoprotein-Associated Phospholipase A2 Gene Is Associated with Catalytic Activities and Cardiovascular Disease in Korean Men
2006
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Therapeutic Benefits from Nanoparticles: The Potential Significance of Nanoscience in Diseases with Compromise to the Blood Brain Barrier
2012
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Small, Dense LDL Particles in Human Plasma
2005
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
2018
Structural insight into TRPV5 channel function and modulation
2019 StandoutNobel
Effects of apolipoprotein E (apoE) isoforms, β-amyloid (Aβ) and apoE/Aβ complexes on Protein Kinase C-α (PKC-α) translocation and amyloid precursor protein (APP) processing in human SH-SY5Y neuroblastoma cells and fibroblasts
2001
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
2007 StandoutScience
Enhanced Expression of Lp-PLA 2 and Lysophosphatidylcholine in Symptomatic Carotid Atherosclerotic Plaques
2008
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Calcium and Cardiovascular Disease
2017
Role ofVHLGene Mutation in Human Cancer
2004 StandoutNobel
Inflammatory Exposure and Historical Changes in Human Life-Spans
2004 StandoutScience
Real-Time PCR Technology for Cancer Diagnostics
2002
Lipoprotein-Associated Phospholipase A2 (Lp-PLA2): A Novel and Promising Biomarker for Cardiovascular Risks Assessment
2013
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Works of Michael M. Hoffmann being referenced
Lack of Evidence for Association of High Altitude Pulmonary Edema and Polymorphisms of the NO Pathway
2003
Competition of Aβ amyloid peptide and apolipoprotein E for receptor-mediated endocytosis
1999
CD14 C(-260)→T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease
2002
C(−260)T polymorphism in the promoter of the CD14 gene is not associated with coronary artery disease and myocardial infarction in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study
2002
Genetic variants of the promoter of the heme oxygenase-1 gene and their influence on cardiovascular disease (The Ludwigshafen Risk and Cardiovascular Health Study)
2009
Low Density Lipoprotein (LDL) Subfractions during Pregnancy: Accumulation of Buoyant LDL with Advancing Gestation
2000
Fluvastatin Slow-Release Lowers Platelet-Activating Factor Acetyl Hydrolase Activity: A Placebo-Controlled Trial in Patients with Type 2 Diabetes
2004
Plasma PCSK9 is increased by Fenofibrate and Atorvastatin in a non-additive fashion in diabetic patients
2010
Differential effects of apolipoprotein E isoforms on phosphorylation at specific sites on tau by glycogen synthase kinase‐3β identified by nano‐electrospray mass spectrometry
2000
Impact of Growth Hormone on Central Nervous Activity, Vigilance, and Tiredness after Short-Term Therapy in Growth Hormone-Deficient Adults
2003
Apolipoprotein E (apoE) uptake and distribution in mammalian cell lines is dependent upon source of apoE and can be monitored in living cells
2003
Alu-Alurecombination underlies the vast majority of largeVHLgermline deletions: Molecular characterization and genotype-phenotype correlations in VHL patients
2009
Vascular endothelial growth factor in pleural effusions of different origin
2005
Association between the A?2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus
2004
Effect of Fluvastatin Slow-Release on Low Density Lipoprotein (LDL) Subfractions in Patients with Type 2 Diabetes Mellitus: Baseline LDL Profile Determines Specific Mode of Action
2002
Genetic variants and haplotypes of lipoprotein associated phospholipase A2 and their influence on cardiovascular disease (The Ludwigshafen Risk and Cardiovascular Health Study)
2008
Recurrent Acute and Chronic Pancreatitis in Two Brothers With Familial Chylomicronemia Syndrome
2006
The interleukin-6 G(–174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction
2002
Covalent Linkage of Apolipoprotein E to Albumin Nanoparticles Strongly Enhances Drug Transport into the Brain
2006
Triglyceride-Rich Lipoproteins Are Associated with Hypertension in Preeclampsia
2003
Fluvastatin Lowers Atherogenic Dense Low-Density Lipoproteins in Postmenopausal Women With the Atherogenic Lipoprotein Phenotype
2001
Comprehensive Mutation Scanning of NF1 in Apparently Sporadic Cases of Pheochromocytoma
2006
Transient Remnant Removal Disease in Acute Fatty Liver of Pregnancy
2004
Germline Mutations of the TMEM127 Gene in Patients with Paraganglioma of Head and Neck and Extraadrenal Abdominal Sites
2011
Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries
2009
Lipoprotein-Associated Phospholipase A2 Predicts 5-Year Cardiac Mortality Independently of Established Risk Factors and Adds Prognostic Information in Patients with Low and Medium High-Sensitivity C-Reactive Protein (The Ludwigshafen Risk and Cardiovascular Health Study)
2007
Impact of Screening Kindreds for SDHD p.Cys11X as a Common Mutation Associated with Paraganglioma Syndrome Type 1
2008
Alanine to Serine Polymorphism at Position 986 of the Calcium-Sensing Receptor Associated with Coronary Heart Disease, Myocardial Infarction, All-Cause, and Cardiovascular Mortality
2007
Functioning Thoracic Paraganglioma: Association with Von Hippel-Lindau Syndrome*
1997
Platelet-Activating Factor Acetylhydrolase Activity Indicates Angiographic Coronary Artery Disease Independently of Systemic Inflammation and Other Risk Factors
2005
Evaluation of the Apo E Genotyping Kit on the LightCycler
2000